Fact CheckerSign in

NCT07394127Completed

A Community-Based Swimming and Inspiratory Muscle Training Intervention to Promote Physical Activity and Asthma Control in Children With Mild Asthma

Source: ClinicalTrials.gov · Last updated 11 Aug 2026

Brief summary (registry, in English)

This randomized controlled trial investigated the effects of adding inspiratory muscle training (IMT) to a structured swimming program on pulmonary function, respiratory muscle strength, ventilatory capacity, perceived exertion, and asthma control in children with mild persistent asthma. Thirty children aged 8-11 years were randomly assigned to either a swimming plus IMT group or a swimming-only group. Both groups participated in a supervised 4-week swimming program, while the experimental group additionally performed IMT twice daily. Pulmonary function tests, respiratory muscle strength, and Childhood Asthma Control Test (C-ACT) scores were assessed before and after the intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
2 Feb 2026
Start date
15 Feb 2026
Primary completion date
25 Feb 2026
Lead sponsor
Gümüşhane Universıty
Diseases
Asthma
NCT number
NCT07394127

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 15 Feb 2026 to the primary completion date, 25 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of medications affecting pulmonary function other than standard asthma therapy

Other illness

  • Other chronic respiratory, cardiovascular, or neuromuscular diseases
  • Recent upper respiratory tract infection

Other

  • Mild intermittent, moderate, or severe persistent asthma
  • Acute asthma exacerbation during the study

Who the study is looking for

  • Children aged 8-11 years
  • Clinically diagnosed mild persistent asthma according to GINA guidelines
  • Baseline FEV₁ ≥ 80% predicted
  • Stable asthma treatment for at least 4 weeks
  • Written informed consent from parents or guardians

Age in the registry: 8 years to 11 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gumushane Univetsity
Coordinator of this site? Confirm its status
GümüşhaneTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.